News for hackers. Stuff that matters.
Re:AstraZeneca may have provided incomplete efficacy data NIAID by IfOnlyYouKnew on Tuesday March 23, 2021 @03:13AM (#26551978)
It’s really a never-ending shit show with this company.

Somehow, I’d still take the vaccine. I remain convinced that none of this is done with malicious intend.

But that confidence is based mostly on a general trust of institutions and procedures in healthcare. It’s a deep reservoir of trust, built up over time. AZ is certainly taking from it more than it is contributing.

Re:AstraZeneca may have provided incomplete efficacy data NIAID by happymellon on Tuesday March 23, 2021 @07:33AM (#26553784)
They use may have too many times in the article for me to take this seriously.

It reads like a smear campaign.

Re:AstraZeneca may have provided incomplete efficacy data NIAID by ethanbond on Tuesday March 23, 2021 @07:36AM (#26553806)
It reads like scientists who have an entire career looking at this sort of data, have spotted something odd in the AZ data, aren’t sure what it’s coming from, and are asking for clarification.
Re:AstraZeneca may have provided incomplete efficacy data NIAID by happymellon on Tuesday March 23, 2021 @08:15AM (#26554130)
If it did, then there would be a reason for this position.

> The DSMB expressed concern that AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data

[because... the data reviewed does not appear to cover the California varient, etc...]

The fact that it is kept vague and not including a reason is not helpful and leads to speculation on how terrible AZ are for not being able to submit proper data. They do confirm that this question has nothing to do with the blood clots which this data helps disprove any proper link.

Re:AstraZeneca may have provided incomplete efficacy data NIAID by icegreentea2 on Tuesday March 23, 2021 @09:03AM (#26554483)
The "may have" appears to come directly the NIAID's news release. If you think that NIAID or the DSMB is trying to smear AZ, then sure.

Otherwise, keeping things vague provides maximum room for maneuver for both groups to resolve the issue without either group losing too much face. This way things can get chalked up to "mis-understandings" of what the requirements were, and AZ can reclarify their data in light of these new requirements.

Re:AstraZeneca may have provided incomplete efficacy data NIAID by refurb on Tuesday March 23, 2021 @09:18AM (#26554595)
AZ just released a statement that indeed, the data submitted was not the final analysis (interim data from Feb) and they promise to submit final data within 48 hrs. And the full data looks similar to the interim.

What’s going on over at AZ? I’m not claiming conspiracy, but clearly there was a miscommunication somewhere.

https://www.astrazeneca.com/content/astraz/media-centre/pres...

“We will immediately engage with the independent data safety monitoring board (DSMB) to share our primary analysis with the most up to date efficacy data. We intend to issue results of the primary analysis within 48 hours.”

Re:AstraZeneca may have provided incomplete efficacy data NIAID by ignoramous on Tuesday March 23, 2021 @08:13AM (#26554118)
> "AstraZeneca did not immediately respond to a Reuters request for comment."

This wouldn't be the first I have seen News Agencies deliberately avoid carrying comments because the PR on the other side of the table happened to not respond "immediately" or "in time" etc;

Re:AstraZeneca may have provided incomplete efficacy data NIAID by gebruikersnaam on Tuesday March 23, 2021 @09:13AM (#26554567)
Re:AstraZeneca may have provided incomplete efficacy data NIAID by addicted on Tuesday March 23, 2021 @08:37AM (#26554289)
The good thing is the actual vaccine development was done by Oxford University that has experience and done a good job with the vaccine itself.

Unfortunately, it’s the related stuff, manufacturing, procurement, trials, contract signing, that was done by AZ and they have almost entirely done a horrible job.

Re:AstraZeneca may have provided incomplete efficacy data NIAID by Throwawayaerlei on Tuesday March 23, 2021 @10:02AM (#26555084)
The good thing is the actual vaccine development was done by Oxford University that has experience and done a good job with the vaccine itself.

They failed for 8 years to get this particular vaccine platform to work, and read some of the other comments, they probably caused more of the infamous string of clinical trial screw ups than AZ.

Re:AstraZeneca may have provided incomplete efficacy data NIAID by scotty79 on Tuesday March 23, 2021 @08:46AM (#26554349)
Remeber that the only reason Astra Zeneca is involved in this is because Bill Gates told Oxford they should find commercial exclusive partner instead opensourcing their vaccine.
Re:AstraZeneca may have provided incomplete efficacy data NIAID by fmajid on Tuesday March 23, 2021 @09:08AM (#26554515)
No. AstraZeneca got involved at the request of the British government. They were not the first choice, GSK was (no 1. vaccine company in the world), but for whatever reason GSK passed, so AstraZeneca, as a British (and Swedish) national champion was chosen, even though they don't have vaccine experience.

There is an excellent investigative report by Le Figaro (in French) that details the many issues the vaccine faced:

https://www.lefigaro.fr/sciences/astrazeneca-le-laboratoire-...

These include friction between AZ and Oxford, the latter insisted on retaining much more control than they would normally have, and this led to serious flaws in the design of experiments for the trials, including not having sufficient numbers of over-65. Furthermore, they mixed samples with different inoculation protocols, raising all sorts of red flags within the scientific community. It does seem the vaccine is effective and safe, but the unforced methodology errors did them no favors, and explain why the FDA and EMA are taking an exceptionally hard look at the data.

Furthermore, production is outsourced to a number of companies with varying level of expertise, and they are poorly supervised by AZ, for instance EU commissioner Thierry Breton performed an inspection in the Belgian subcontractor that has been having problems that led to AZ not meeting its contractual commitments to the EU (and a diplomatic crisis between the EU and UK), and found production and quality control issues the AZ headquarters were unaware of.

Re:AstraZeneca may have provided incomplete efficacy data NIAID by kossTKR on Tuesday March 23, 2021 @03:27PM (#26559263)
How is that relevant to the "Open Sourcing" of the vaccine?

In my eyes the fact that so much of vaccine production is in private hands is a classic example of "privatising profits" because everyone paid for the research with their taxes.

Gates is a super billionare only looking out for his bank account, through the good old "philantrophy PR" scheme. He is actively doing class warfare by close sourcing vaccines. Completely in line with the rest of his endeavours.

Re:AstraZeneca may have provided incomplete efficacy data NIAID by scotty79 on Tuesday March 23, 2021 @02:03PM (#26558110)
That doesn't contradict what I said. Oxford wanted to opensource the vaccine before Bill Gates influenced them.
Re:AstraZeneca may have provided incomplete efficacy data NIAID by moystard on Tuesday March 23, 2021 @09:12AM (#26554553)
The article is not accessible because of the hard paywall. Frustrating as it looks like an interesting read.
Re:AstraZeneca may have provided incomplete efficacy data NIAID by sschueller on Tuesday March 23, 2021 @08:09AM (#26554079)
It's difficult. Do you trust J&J after what they did with their baby powder [1]? Or Pfizer [2], or Moderna who's vaccine is the most expensive and new to the scene [3]?

[1] https://www.reuters.com/investigates/special-report/johnsona...

[2] https://en.wikipedia.org/wiki/Abdullahi_v._Pfizer,_Inc.

[3] - Oxford/AstraZeneca: €1.78 (£1.61). - Johnson & Johnson: $8.50 (£6.30). - Sanofi/GSK: €7.56. - Pfizer/BioNTech: €12. - CureVac: €10. - Moderna: $18.

Re:AstraZeneca may have provided incomplete efficacy data NIAID by yunohn on Tuesday March 23, 2021 @08:32AM (#26554243)
Wow, I’d never heard of the Pfizer case. Here’s a crazy snippet:

“Pfizer argued that it was not required to obtain informed consent for experimental drug trials in Africa, and that any case should be heard in Nigeria”

Re:AstraZeneca may have provided incomplete efficacy data NIAID by juanani on Tuesday March 23, 2021 @09:25AM (#26554665)
>Wow, I’d never heard of the Pfizer case.

From the Wiki article

>Pfizer subsequently settled the case out of court with a $75 million settlement that was subject to a confidentiality clause.

Does the confidentiality clause also suppress media or is that a separate payment to whoever is putting their nose into it? I'm curious how these stories get out, and are there others that don't ever reach Wiki articles?

Re:AstraZeneca may have provided incomplete efficacy data NIAID by thehappypm on Tuesday March 23, 2021 @11:28AM (#26556157)
Cost is by far the least interesting part of this for me. These are all astoundingly affordable vaccines. $18 is the cost of a big bottle of Claritin!
Re:AstraZeneca may have provided incomplete efficacy data NIAID by spazrunaway on Tuesday March 23, 2021 @09:17AM (#26554588)
Conspiracy theorist. Trust the science! /s
Re:AstraZeneca may have provided incomplete efficacy data NIAID by sschueller on Tuesday March 23, 2021 @09:22AM (#26554638)
I'm definitely getting the Vaccine, just saying, it's not easy to just blindly trust anyone.